Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure

Previous studies have shown that an epidermal growth factor‐based formulation (Heberprot‐P) can enhance granulation of high‐grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects of this administration up to complete wound closure. A pilot study in 20 diabetic pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int Wound J
Prif Awduron: Fernández‐Montequín, José I, Betancourt, Blas Y, Leyva‐Gonzalez, Gisselle, Mola, Ernesto L, Galán‐Naranjo, Katia, Ramírez‐Navas, Mayte, Bermúdez‐Rojas, Sergio, Rosales, Felix, García‐Iglesias, Elizeth, Berlanga‐Acosta, Jorge, Silva‐Rodriguez, Ricardo, Garcia‐Siverio, Marianela, Martinez, Luis H
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Publishing Ltd 2009
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951202/
https://ncbi.nlm.nih.gov/pubmed/19291119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-481X.2008.00561.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg